Free cookie consent management tool by TermsFeed GPCRmd
× Due to a recent server update, this page will be slow for the next 1-2 hours. We apologize for any inconvenience this may cause.

Simulation report

Technical information

General information

Name: Structure of beta2 adrenoceptor (apoform)

PDB id: 4LDO

Activation state: Active

Submitted by: Andrea Catte, University of Cagliari

System setup

Solvent type: TIP3P

Membrane type: Heterogeneous

Membrane composition: POPC (80.0%), CHL1 (20.0%)

Ionic composition: Sodium ion (344 mM), Chloride (394 mM)

Number of molecules:

Water: 10000

POPC: 260

Chloride: 71

Cholesterol: 65

Sodium ion: 62

Noreinefrina: 1

Beta-2 adrenergic receptor: 1

Total number of atoms: 117652

Simulation details

Software and version: GROMACS, 2019.6

Forcefield and version: CHARMM, CHARMM36m

Time step : 2.0 fs

Delta : 0.5 ns

Replicates: 5

Accumulated simulation time: 1.0005 µs

Additonal parameters: Available at "Simulation protocol & starting files"

References

Biswas, AD; Catte, A; Mancini, G; Barone, V.. 2021. Analysis of L-DOPA and droxidopa binding to human β2-adrenergic receptor. Biophysical journal. doi: 10.1016/j.bpj.2021.11.007. (https://doi.org/10.1016/j.bpj.2021.11.007)



GPCRmd publication page: 1476

Simulation components

Receptor

Visualization and trajectory sharing powered by NGL viewer and MDSrv

Open with GPCRmd Workbench

Mutations

Table of simulated mutations

(Mutations shown in blue at the viewer)

Residue ID Residue seq. position Generic num. From To
58 29 1x28 D X


Other molecules



Water

Specific State ID: 5019

(10000 molecules)

H2O


POPC

Specific State ID: 5018

(260 molecules)


Sodium ion

Specific State ID: 5016

(62 molecules)

Na+


Chloride

Specific State ID: 5017

(71 molecules)

Cl-


Cholesterol

Specific State ID: 5022

(65 molecules)


Noreinefrina

Specific State ID: 1358

(1 molecule)


PARTNER SERVERS

GPCRdb

GPCR-ModSim

GPCRM

NMRlipids

HomolWat

Hybrid MM/CG Webserver

CONTACT & LINKS

Documentation

Cite us

Privacy policy

Cookies policy

Disclaimer

Terms & Conditions

SUPPORTED BY

ERNEST (COST Action CA18133)

GLISTEN (COST Action CM1207)

GPCRForum